Position in VRTX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$103,299,970
+$1,401,776 QoQ
Shares Held
207,960
-8.9% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#111
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. VRTX ranks #2 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
259,317 | $161,694,522 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
207,960 | $103,299,970 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,115,730 | $87,328,187 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,696 | $70,349,506 | |
| 5 | CYTK |
Cytokinetics Inc
|
385,130 | $32,809,224 | |
| 6 | RPRX |
Royalty Pharma plc
|
567,497 | $31,819,556 | |
| 7 | ASND |
Ascendis Pharma A/S
|
119,085 | $31,762,351 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
272,900 | $31,293,443 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $103,299,970 | 207,960 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $101,898,194 | 228,195 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $82,789,428 | 182,613 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $85,196,973 | 217,539 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $207,095,019 | 465,173 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $235,552,705 | 485,856 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $188,893,683 | 469,068 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $242,867,100 | 522,205 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $236,260,190 | 504,054 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $215,442,353 | 515,400 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $217,243,859 | 533,913 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $166,937,107 | 480,063 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $132,658,105 | 376,966 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $121,801,651 | 386,586 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $109,740,442 | 380,014 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $127,280,336 | 439,595 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $124,421,837 | 441,541 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $113,930,628 | 436,566 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $72,419,468 | 329,779 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $58,031,013 | 319,924 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $69,685,948 | 345,613 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $103,079,939 | 479,687 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $142,369,561 | 602,393 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $168,916,040 | 620,741 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $171,854,230 | 591,968 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $138,208,260 | 580,829 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||